RxDoctor Payments Data

Orlando Gonzalez

Medical · Miami, FLNPI 1619282126

Payments from drug & device makers

$505in general payments, 2019–2025

Across 24 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$97
  • AbbVie$97
  • AstraZeneca$93
  • Novo Nordisk$75
  • Lilly USA, LLC$44
  • Sunovion Pharmaceuticals Inc.$32
  • plus $68 from 3 others

What the payments were for

  • Food & beverage$505100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$505 in reported general payments places this provider in the 45th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$4,964
Medicare patients
16
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban72$56,451
JardianceEmpagliflozin43$55,723
LinzessLinaclotide102$53,374
OzempicSemaglutide26$24,571
FarxigaDapagliflozin Propanediol36$24,070
MyrbetriqMirabegron37$20,331
TrulicityDulaglutide17$17,859
JanuviaSitagliptin Phosphate23$13,963
SynjardyEmpagliflozin/Metformin Hcl20$11,808
XareltoRivaroxaban20$10,922
Synjardy XrEmpagliflozin/Metformin Hcl13$10,024
Diclofenac Sodium347$7,121
Atrovent HfaIpratropium Bromide15$6,692
PremarinEstrogens, Conjugated12$5,758
Rosuvastatin Calcium526$4,414

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy, Synjardy Xr$15$77,55576 claims
AbbVieLinzess, Synthroid$97$54,968133 claims
AstraZenecaFarxiga, Symbicort$93$26,52247 claims
Novo NordiskOzempic$75$24,57126 claims
Lilly USA, LLCTrulicity$44$17,85917 claims
Johnson & JohnsonXarelto$24$10,92220 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,031 medical providers in Florida.

Other medical in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →